Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 5/20 | 0.61 |
| ▸ | SUMO2 | P61956 | 2/20 | 0.55 |
| ▸ | SUMO1 | P63165 | 2/20 | 0.55 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.55 |
| ▸ | SENP2 | Q9HC62 | 2/20 | 0.55 |
| ▸ | APEX1 | P27695 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.43 |
| ▸ | SENP3 | Q9H4L4 | 1/20 | 0.42 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.39 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | NT5E | P21589 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13880551 | 0.91 | ENPP2 (0.51) | ENPP2SUMO2SUMO1SENP7SENP2 | |
| SCHEMBL13069596 | 0.87 | CYP1A2 (0.51) | ENPP2SUMO2SUMO1SENP7SENP2 | |
| SCHEMBL14441044 | 0.87 | SUMO2 (0.62) | ENPP2SUMO2SUMO1SENP7SENP2 | |
| SCHEMBL17384210 | 0.86 | ENPP2 (0.51) | ENPP2SUMO2SUMO1SENP7SENP2 | |
| SCHEMBL14388859 | 0.84 | CYP1A2 (0.55) | ENPP2SUMO2SUMO1SENP7SENP2 | |
| SCHEMBL14546770 | 0.83 | SENP2 (0.40) | ENPP2SUMO2SUMO1SENP7SENP2 | |
| SCHEMBL17384219 | 0.82 | ENPP2 (0.52) | ENPP2SUMO2SUMO1SENP7SENP2 | |
| SCHEMBL6346835 | 0.82 | APEX1 (0.73) | ENPP2SUMO2SUMO1SENP7SENP2 | |
| SCHEMBL11670482 | 0.82 | APEX1 (0.73) | ENPP2SUMO2SUMO1SENP7SENP2 | |
| SCHEMBL11670965 | 0.82 | APEX1 (0.73) | ENPP2SUMO2SUMO1SENP7SENP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9403987-B2 | Charged particles | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| US-9403987-B2 | Charged particles | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| US-20120229884-A1 | CHARGED PARTICLES | BASF SE (DE) | 2012-09-13 | — | — | US | disclosed |
| US-20120229884-A1 | CHARGED PARTICLES | BASF SE (DE) | 2012-09-13 | — | — | US | disclosed |
| WO-2010149505-A2 | CHARGED PARTICLES | BASF SE (DE) | 2010-12-29 | — | — | WO | disclosed |
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | BASF SE (DE) | 2009-04-16 | — | — | US | disclosed |
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | BASF SE (DE) | 2009-04-16 | — | — | US | disclosed |
| WO-2007063024-A2 | KERATIN-BINDING EFFECTOR MOLECULES CONTAINING REACTIVE DYES | BASF SE (DE) | 2007-06-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | KRT18, KLK3, KLKB1 | ENPP2 3626/4885SUMO2 1017/4885SUMO1 1133/4885 |
| US-20120229884-A1 | CHARGED PARTICLES | POLE3, POLD3, IPO4 | ENPP2 1649/4885SUMO2 314/4885SUMO1 436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.